Prime Medicine Inc (PRME) is destined for greater heights as its last quarter sales were 590 K
On Friday, Prime Medicine Inc (NASDAQ: PRME) was -4.05% drop from the session before settling in for the closing price of $4.20. A 52-week range
On Friday, Prime Medicine Inc (NASDAQ: PRME) was -4.05% drop from the session before settling in for the closing price of $4.20. A 52-week range
Prime Medicine Inc (NASDAQ: PRME) flaunted slowness of -10.54% at $3.99, before settling in for the price of $4.46 at the close. Taking a more
Prime Medicine Inc (NASDAQ: PRME) kicked off on Friday, up 15.26% from the previous trading day, before settling in for the closing price of $3.80.
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.